Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Stumpf

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|July 5, 2024
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Nature|February 28, 2012
The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C Hsieh, Yi Liu, Merritt P Edlind, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) InhibitionSiegfried H Reich, Paul A Sprengeler, Gary G Chiang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|July 5, 2024
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Nature|February 28, 2012
The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C Hsieh, Yi Liu, Merritt P Edlind, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) InhibitionSiegfried H Reich, Paul A Sprengeler, Gary G Chiang, et al.
Pageof 2